| GPRO 1.23 40.38% | PCG 14.06 5.95% | LIDR 1.47 27.83% | NVDA 217.44 -1.51% | HKPD 0.1815 -45.54% | TSLL 9.33 -6.42% | NVD 4.05 3.05% | RITR 0.0882 -4.13% | NIO 4.055 -4.14% | FLYE 2.2 61.76% | INTC 88.97 -0.60% | ONDS 7.04 -8.05% | NU 14.46 -0.62% | BITO 10.38 -2.35% | RZLV 2.39 -17.30% | PATH 18.14 -2.84% | SOXL 105.91 -6.10% | AAL 12.95 -3.57% | NOK 9.93 -2.07% | TQQQ 69.15 -3.85% | SPCX 142.23 -1.02% | AAPL 325.13 2.61% | IBIT 43.76 -2.04% | F 13.83 -0.79% | HYG 79.1 -0.89% | SQQQ 39.97 3.79% | PLUG 2.09 -3.24% | SOXS 52.22 6.53% | BIAF 6.59 44.52% | SGOV 100.41 -0.28% | BTG 5.2 -5.11% | CDE 20.2 -2.79% | QID 14.59 2.53% | SOFI 17.05 -4.64% | PFE 28.55 0.32% | SPY 761.78 -0.69% | BMNR 23.37 -7.70% | GRAB 3.46 -2.26% | AIM 0.236 4.42% | RIG 5.92 1.89% | TSLA 356.09 -3.22% | FRVO 19.75 28.41% | LQD 105.22 -0.93% | QQQ 707.64 -1.27% | SSM 4.755 77.43% | IREN 36.82 -0.79% | ETHA 18.23 -2.62% | XLE 64.77 1.27% | T 26.015 0.48% | EWZ 36.57 1.50%

InfuSystem Holdings (AMEX: INFU) Reports Mixed Q1 2026 Financial Results

InfuSystem Holdings, Inc. (AMEX: INFU) is a healthcare company that provides infusion pumps and related services. The company operates through two main divisions. Its Device Solutions segment handles the sale and rental of medical equipment, while its Patient Services segment provides the necessary supplies and support for infusion therapies.

On May 7, 2026, InfuSystem Holdings reported its first-quarter financial results. The company announced an earnings per share of $0.05, which beat the consensus estimate of $0.04, as highlighted by Zacks. This marks a significant turnaround from the same quarter last year, when the company reported a loss of $0.01 per share.

However, the company's total revenue for the quarter was $33.68 million, missing the estimate of $34.35 million. This figure represents a 3% decrease compared to the $34.72 million in revenue from the prior year. The decline was mainly caused by a 17% drop in revenue from the Device Solutions segment.

Despite the overall revenue decline, the Patient Services segment showed growth, with its revenue increasing by 6% to $22.10 million. This growth helped improve the company's overall profitability. Gross profit rose by 3% to $19.70 million, and the company achieved a net income of $1.00 million for the quarter.

From a financial health perspective, InfuSystem Holdings maintains a current ratio of 2.14. This ratio shows a company's ability to pay its short-term obligations, indicating InfuSystem Holdings has 2.14 times more current assets than liabilities. The company also has a low debt-to-equity ratio of 0.39, suggesting it relies more on equity than debt to finance its assets.

Published on: May 7, 2026